Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1996 Jul;224(1):1–3. doi: 10.1097/00000658-199607000-00001

Chemoembolization for hepatocellular carcinoma. What, when, and for whom?

T Lehnert, C Herfarth
PMCID: PMC1235239  PMID: 8678609

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bismuth H., Morino M., Sherlock D., Castaing D., Miglietta C., Cauquil P., Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992 Apr;163(4):387–394. doi: 10.1016/0002-9610(92)90039-t. [DOI] [PubMed] [Google Scholar]
  2. Fujio N., Sakai K., Kinoshita H., Hirohashi K., Kubo S., Iwasa R., Lee K. C. Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver. World J Surg. 1989 Mar-Apr;13(2):211–218. doi: 10.1007/BF01658403. [DOI] [PubMed] [Google Scholar]
  3. Harada T., Matsuo K., Inoue T., Tamesue S., Inoue T., Nakamura H. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg. 1996 Jul;224(1):4–9. doi: 10.1097/00000658-199607000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Koo J., Fung K., Siu K. F., Lee N. W., Lett Z., Ho J., Wong J., Ong G. B. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma. Cancer. 1983 Nov 15;52(10):1952–1956. doi: 10.1002/1097-0142(19831115)52:10<1952::aid-cncr2820521029>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  5. Lehnert T., Otto G., Herfarth C. Therapeutic modalities and prognostic factors for primary and secondary liver tumors. World J Surg. 1995 Mar-Apr;19(2):252–263. doi: 10.1007/BF00308635. [DOI] [PubMed] [Google Scholar]
  6. Lin D. Y., Liaw Y. F., Lee T. Y., Lai C. M. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial. Gastroenterology. 1988 Feb;94(2):453–456. doi: 10.1016/0016-5085(88)90436-2. [DOI] [PubMed] [Google Scholar]
  7. Madden M. V., Krige J. E., Bailey S., Beningfield S. J., Geddes C., Werner I. D., Terblanche J. Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut. 1993 Nov;34(11):1598–1600. doi: 10.1136/gut.34.11.1598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pelletier G., Roche A., Ink O., Anciaux M. L., Derhy S., Rougier P., Lenoir C., Attali P., Etienne J. P. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol. 1990 Sep;11(2):181–184. doi: 10.1016/0168-8278(90)90110-d. [DOI] [PubMed] [Google Scholar]
  9. Raoul J. L., Guyader D., Bretagne J. F., Duvauferrier R., Bourguet P., Bekhechi D., Deugnier Y. M., Gosselin M. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med. 1994 Nov;35(11):1782–1787. [PubMed] [Google Scholar]
  10. Takenaka K., Yoshida K., Nishizaki T., Korenaga D., Hiroshige K., Ikeda T., Sugimachi K. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg. 1995 Apr;169(4):400–405. doi: 10.1016/s0002-9610(99)80184-6. [DOI] [PubMed] [Google Scholar]
  11. Wu C. C., Ho Y. Z., Ho W. L., Wu T. C., Liu T. J., P'eng F. K. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg. 1995 Jan;82(1):122–126. doi: 10.1002/bjs.1800820141. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES